Sign in

CIK 0001660334

  • Non-accelerated filer
  • Smaller reporting company

Verrica Pharmaceuticals Inc.

Sign in to watch
Ticker
VRCA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
463137900
Phone
+1 484-453-3300
Business address
44 WEST GAY STREET, SUITE 400, WEST CHESTER, PA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2018-06-19 Degnan Chris Chief Financial Officer Purchase +3,000 $15.00 $45K 3,000
2018-06-19 Bonaccorso Joe Chief Commercial Officer Purchase +1,000 $15.00 $15K 1,000
2018-06-19 Manning Paul B Director Purchase +200,000 $15.00 $3.0M 7,987,783
2018-06-19 Manning Paul B Director Purchase +100,000 $15.00 $1.5M 1,260,244
2018-06-19 PERCEPTIVE ADVISORS LLC 10% owner Conversion +1,130,679 1,130,679
2018-06-19 PERCEPTIVE ADVISORS LLC 10% owner Conversion +1,279,733 2,410,412
2018-06-19 PERCEPTIVE ADVISORS LLC 10% owner Purchase +1,000,000 $15.00 $15.0M 3,410,412
2018-06-19 PERCEPTIVE ADVISORS LLC 10% owner Conversion · Series B Preferred Stock −1,937,984 0
2018-06-19 PERCEPTIVE ADVISORS LLC 10% owner Conversion · Series C Preferred Stock −2,193,463 0
2018-06-19 Stalfort Sean Director Conversion +394,295 421,639
2018-06-19 Stalfort Sean Director Conversion · Series A Convertible Preferred Stock −394,295 0
2018-06-19 OCLASSEN GLENN A Director Conversion +200,734 290,421
2018-06-19 OCLASSEN GLENN A Director Conversion · Series A Convertible Preferred Stock −200,734 0
2018-06-19 Manning Paul B Director Conversion +7,754,783 7,754,783
2018-06-19 Manning Paul B Director Conversion +1,132,900 1,160,244
2018-06-19 Manning Paul B Director Conversion +256,634 256,634
2018-06-19 Manning Paul B Director Conversion · Series A Convertible Preferred Stock −7,754,783 0
2018-06-19 Manning Paul B Director Conversion · Series A Convertible Preferred Stock −1,132,900 0
2018-06-19 Manning Paul B Director Conversion · Series A Convertible Preferred Stock −256,634 0
2018-06-14 Goldenberg Gary Director Grant or award · Stock Option (Right to Buy) +17,502 17,502

Page 22 of 23 · 444 trades